Related Experiment Video
Updated: May 12, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Trends in brachytherapy utilization in Canada from 2011 to 2020
Mirta Dumančić1,2, Yujing Zou1,2, Harry Glickman1,2
1Medical Physics Unit, Department of Oncology, Faculty of Medicine, McGill University, Montréal, QC, Canada.
Brachytherapy utilization in Canada showed regional variations from 2011-2020. While high-dose-rate brachytherapy increased, low-dose-rate declined, with overall national use remaining stable despite provincial differences.
Area of Science:
- Oncology
- Radiotherapy
- Medical Physics
Background:
- Brachytherapy is a conformal, cost-effective radiotherapy. Its clinical use has declined in many areas.
- Investigating brachytherapy utilization trends in Canadian provinces (2011-2020) is crucial.
Purpose of the Study:
- To analyze national and provincial brachytherapy utilization trends.
- To identify factors influencing brachytherapy practice variations across Canada.
Main Methods:
- A national survey of medical physicists in Canadian cancer centres.
- Collected data on brachytherapy types, treatments, indications, and logistics.
- Included complementary data for Québec to extend provincial analysis.
Main Results:
- 25 of 39 centres participated; High-Dose-Rate (HDR) brachytherapy increased (60-100% of treatments), Low-Dose-Rate (LDR) declined.
- Utilization decreased in Alberta and British Columbia; increased in Ontario, Nova Scotia, Saskatchewan.
- No significant change nationally or in Manitoba and Québec.
Conclusions:
- Significant regional disparities in brachytherapy utilization and practices exist.
- Reimbursement, personnel, infrastructure, and clinician preferences influence trends.
- HDR use is increasing nationally, LDR is declining, but overall utilization was sustained 2011-2020.
Related Concept Videos
Current Trends in Nursing II
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Current Trends in Nursing I
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

